Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Bronchial Asthma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial to evaluate the efficacy and safety of HSK31858 tablets in patients with bronchial asthma is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchial Asthma

Drugs mentioned

• HSK31858 tablets (HSK31858)

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Bronchial Asthma | Phase 2 | Status: ENROLLING_BY_INVITATION